About
Olema Oncology is a clinical-stage biopharmaceutical company focused on developing therapies that activate estrogen receptor remodeling to treat endocrine-resistant breast cancer.
Explore Olema Oncology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.